Status:
COMPLETED
Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT)
Lead Sponsor:
The University of New South Wales
Collaborating Sponsors:
Northside Clinic, Australia
The Melbourne Clinic, Australia
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Electroconvulsive Therapy (ECT) remains essential to contemporary psychiatric practice and is one of the safest and most effective treatments available for depression. Despite modern advances in pharm...
Eligibility Criteria
Inclusion
- Subjects meet criteria for a DSM-IV-TR Major Depressive Episode
- Total MADRS score \>/= 25
- Age \>/= 18 years
- Educated or working in an English medium setting
Exclusion
- Diagnosis (as defined by DSM-IV-TR) of any psychotic disorder (lifetime with exception of Major Depressive Episode with psychotic features); rapid cycling bipolar disorder, eating disorder (current or within the past year); obsessive compulsive disorder (lifetime); post-traumatic stress disorder (current or within the past year).
- history of drug or alcohol abuse or dependence (as per DSM-IV-TR) in the last 6 months (except nicotine and caffeine).
- ECT in last 3 months
- Subject requires an urgent clinical response due to inanition, psychosis or high suicide risk
- unable to give informed consent
- score \< 24 on Mini Mental State Examination
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00870805
Start Date
January 1 2009
End Date
January 1 2013
Last Update
February 27 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
St George Hospital
Kogarah, New South Wales, Australia, 2217
2
Wandene Private Hospital
Kogarah, New South Wales, Australia, 2217
3
The Melbourne Clinic
Melbourne, Victoria, Australia